Asset Dedication LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Asset Dedication LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37K	Buy	+15	New	+$2.03K	﹤0.01%	1018
2025 Q4	–	Sell	-235	Closed	-$23.5K	–	1178
2025 Q3	$23.5K	Buy	+235	New	+$21.2K	﹤0.01%	647
2019 Q2	–	Sell	-450	Closed	-$41K	–	647
2019 Q1	$41K	Buy	+450	New	+$38.3K	0.01%	294

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Asset Dedication LLC's XBI Position: Q2 2026 in Review

Asset Dedication LLC opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 15 shares worth $2.37K. The stake represents ﹤0.01% of the portfolio and ranks #1018 among its holdings. This is a return to the name: Asset Dedication LLC previously reported a position in XBI as recently as Q3 2025.

Asset Dedication LLC first reported a position in XBI in Q1 2019 and has held it in 3 quarters since. The position peaked at $41K in Q1 2019. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Asset Dedication LLC held 15 shares of State Street SPDR S&P Biotech ETF worth $2.37K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Asset Dedication LLC position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1018 holding.
Asset Dedication LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 3 quarters since.
Asset Dedication LLC's State Street SPDR S&P Biotech ETF position peaked at $41K in Q1 2019.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.